Systemic immunity in cancer | Nature Reviews Cancer
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative - The Lancet Rheumatology
Severe and multifaceted systemic immunosuppression caused by experimental cancers of the central nervous system requires release of non-steroid soluble mediators | bioRxiv
Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making - Hellemans - 2021 - Transplant International -
Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer - ScienceDirect
Cancers | Free Full-Text | Mechanisms of Immunosuppression in Colorectal Cancer | HTML
Frontiers | COVID-19 in Immunosuppressed Children
Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States | American Society of Nephrology
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review | Journal of the American Heart Association
IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines | PNAS
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy | Nature Reviews Clinical Oncology
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation - ScienceDirect
Frontiers | Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
Targeted regulation of lymphocytic ER stress response with an overall immunosuppression to alleviate allograft rejection - ScienceDirect
The need for minimization strategies: current problems of immunosuppression - Bamoulid - 2015 - Transplant International - Wiley Online Library
Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations - eBioMedicine
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
The need for minimization strategies: current problems of immunosuppression - Bamoulid - 2015 - Transplant International - Wiley Online Library
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative - The Lancet Rheumatology
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
Immunosuppression following heart transplantation: prospects and challenges | Immunotherapy
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
Tumor mutational burden and immunotherapy in gliomas: Trends in Cancer
